This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Last recorded trade on: March 21, 2025
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
HK$0.24
Share price
0.00%
Change (1 day)
-94.89%
Change (1 year)
Categories
Advaxis (ADXS) - Net assets
Net assets on the balance sheet as of December 2023 : -HK$0.2 Billion
According to Advaxis's latest financial reports the company has -HK$0.2 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Advaxis - Net assets on balance sheet (from 2019 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $-HK$0.2 Billion | 2120.84% |
| 2022-12-31 | $-HK$8.59 Million | -103.22% |
| 2021-12-31 | $HK$0.26 B | -10.52% |
| 2020-12-31 | $HK$0.29 B | -198.2% |
| 2019-12-31 | $-HK$0.31 Billion | 77.08% |
| 2018-12-31 | $-HK$0.18 Billion |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Inovio Pharmaceuticals INO | HK$0.40 B | -309.90% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | HK$97.21 M | -150.72% | 🇺🇸 USA |
 Heska Corporation
HSKA | HK$3.27 B | -1,810.57% | 🇺🇸 USA |